Study of the relationships of polymorphisms of the folate cycle genes with the levels of homocysteine and folic acid as risk factors of cardiovascular disorders in the post-covid period
DOI:
https://doi.org/10.26641/2307-0404.2024.3.313071Ключевые слова:
enzymes of the folate cycle, polymorphisms, recessive homozygous mutations, homocysteine, folic acid, cardiometabolic risk, coronavirus diseaseАннотация
Enzymes of the folate cycle participate in the process of remethylation of homocysteine (HC) to methionine, where folates are coenzymes for methyl transfer. The aim of the work was to identify the interrelationships of gene polymorphisms of associations between folate cycle enzyme gene polymorphisms and cardiometabolic risk factors such as increased serum homocysteine levels and folic acid deficiency in patients in the post-covid period. In 51 patients who suffered from COVID-19, a general clinical and laboratory examination, and assessment of serum homocysteine and folic acid concentrations by immunoenzymatic method was carried out. Polymorphisms of the genes: methylenetetrahydrofolate reductase (677C>T and 1298A>C), methionine synthase-reductase (66A>G) and methionine synthase (2756A>G) were determined by real time polymerase chain reaction. For each of the named polymorphisms, the examined patients were divided into 3 groups according to the nucleotide alleles in the corresponding position: 1) homozygous dominant, 2) heterozygous and 3) homozygous recessive. For the methylenetetrahydrofolatereductase gene at position 677, serum levels of homocysteine and folate did not differ between the groups 1 and 2 with genotypes 677 C/C (n=26) and 677C/T (n=21), (p>0.05); in group 3, the recessive genotype 677 T/T was found in only 4 people (8%), that did not allow comparison of indices. The distribution of patients into 3 groups according to the genotype of the same gene at position 1298 revealed that the recessive 1298 C/C mutation in group 3 (n=9) associated with an increased homocysteine level (19.56±1.89 μmol/l), versus 10.68±0.76 (p=0.012) and 11.63±1.25 μmol/l (p=0.013) in groups 1 and 2, with no difference in folate levels between groups. Group 3 differed by a higher degree of obesity, a higher frequency of hypertension disease and chronic heart failure (in 85% of patients in group 3, against 41 and 50% in groups 1 and 2), a higher number of platelets, a longer duration of hospitalization due to COVID-19, a higher level of D-dimer. The study of groups of patients, divided depending on the genotype of methioninesynthase reductase at position 66, showed that carriers of the recessive homozygous 66 G/G mutation (group 3, n=15) had increased serum homocysteine level (16.56±1.64 μmol/l) in comparison with individuals of group 1 (n=17) 66 A/A (10.28±1.17 μmol/l; p=0.004) and group 2 (n=19) 66 A/G (11.32±1.17 μmol/l, p=0.013). In group 3, a longer duration of hospitalization due to COVID-19 was noted (17.15±1.65 vs. 11.88±0.97 days, p=0.008), higher frequency of hypertension (67% vs. 35%) and heart failure (67% against 29%) compared to group 1. The use of a molecular genetic approach made it possible to establish that the presence of recessive mutations of the folate cycle genes is associated with a potential predisposition to hyperhomocysteinemia, thrombophilia, severe forms of cardiometabolic complications and coronavirus disease.
Библиографические ссылки
Perła-Kaján J, Jakubowski H. COVID-19 and One-Carbon Metabolism. Int J MolSci. 2022 Apr;23(8):4181. doi: https://doi.org/10.3390/ijms23084181
Liu F, Chen J, Li Z, Meng X. Recent advances in epigenetics of age-related kidney diseases. Genes. 2022;13(5):796. doi: https://doi.org/10.3390/genes13050796
Kern B, Podkrajšek K, Kovač J, Šket R, Bizjan B, Tesovnik T, et al. The Role of epigenetic modifications in late complications in type 1 diabetes. Genes (Basel). 2022 Apr;13(4):705. doi: https://doi.org/10.3390/genes13040705
Andreichyn M, Nychyk N, Zavidniuk N, Yosyk Ya, Ishchuk I, Ivakhiv O. [COVID-19: epidemiology, clinic, diagnosis, treatment and prevention]. Infektsiini khvoroby. 2020;2(100):41-55. Ukrainian. doi: https://doi.org/10.11603/1681-2727.2020.2.11285
Sun J, Jiang X, Zhao M, Ma L, Pei H, Liu N, et al. Association of Methylenetetrahydrofolate Reductase C677T Gene Polymorphisms with Mild Cognitive Impair-ment Susceptibility: A Systematic Review and Meta-Analysis. Behav Neurol. 2021;2021:2962792. doi: https://doi.org/10.1155/2021/2962792
Raina JK, Panjaliya RK, Dogra V, Sharma S, Anupriya KP. Association of МТГФР and MS/MTR gene polymorphisms with congenital heart defects in North Indian population (Jammu and Kashmir): a case-control study encompassing meta-analysis and trial sequential analysis. BMC Pediatr. 2022 Apr 25;22(1):223. doi: https://doi.org/10.1186/s12887-022-03227-z
Ren ZJ, Zhang YP, Ren PW, Yang B, Deng S, Peng ZF, et al. Contribution of MTR A2756G polymorphism and MTRR A66G polymorphism to the risk of idiopathic male infertility. Medicine (Baltimore). 2019 Dec;98(51):e18273. doi: https://doi.org/10.1097/MD.0000000000018273
Santilli F, Davì G, Patrono C. Homocysteine, me-thylenetetrahydrofolatereductase, folate status and atherothrombosis: A mechanistic and clinical perspective. Vascul Pharmacol. 2016 Mar;78:1-9. doi: https://doi.org/10.1016/j.vph.2015.06.009
Ponti G, Pastorino L, Manfredini M, Ozben T, Oliva G, Kaleci S, et al. COVID‐19 spreading across world correlates with C677T allele of the methylenetetra-hydrofolate reductase gene prevalence. J Clin Lab Anal. 2021;35(7):e23798. doi: https://doi.org/10.1002/jcla.23798
Gogu AE, Jianu DC, Dumitrascu V, Ples H, Stroe AZ, et al. MTHFR Gene Polymorphisms and Car-diovascular Risk Factors, Clinical-Imagistic Features and Outcome in Cerebral Venous Sinus Thrombosis. Brain Sci. 2020;11(1):23. doi: https://doi.org/10.3390/brainsci11010023
Kovács E, Bereczky Z, Kerényi A, Laczik R, Na-gy V, Kovács DÁ, et al. Clinical /Investigation of Hereditary and Acquired Thrombophilic Factors in Patients with Venous and Arterial Thromboembolism. Int J Gen Med. 2023 Nov 22;16:5425-37. doi: https://doi.org/10.2147/IJGM.S412551
Ponti G, Ruini C, Tomasi A. Homocysteine as a potential predictor of cardiovascular risk in patients with COVID‐19. Med Hypotheses. 2020;143:109859. doi: https://doi.org/10.1016/j.mehy.2020.109859
Si T, Zhang W, Fu X, Wang Y, Liu D, Wu Q. Reference intervals of homocysteine in apparently healthy Chinese Han ethnic adults. J Lab Med 2022;46(2):125-32. doi: https://doi.org/10.1515/labmed-2021-0135
Keskin O, Seremet Keskin A, Nilgün Seremet. Association between low serum folic acid and vitamin B12 levels with COVID-19 prognosis. Progr Nutr [Internet]. 2022 Sep. 27 [cited 2024 Mar 4];24(3):e2022104.
Abildgaard A, et al. Reference intervals for plasma vitamin B12 and plasma/serum methylmalonic acid in Danish children, adults and elderly. Clinica chimica acta; international journal of clinical chemistry. 2022;525:62-8. doi: https://doi.org/10.1016/j.cca.2021.12.015
Galukande M, Jombwe J, Fualal J, Baingana R, Gakwaya A. Reference values for serum levels of folic acid and vitamin B12 in a young adult Ugandan population. Afr Health Sci. 2011 Jun;11(2):240-3. PMID: 21857855; PMCID: PMC3158514.
Golovanova IA, Belikova IV, Lyakhova NO. [Fundamentals of medical statistics. Study guide for graduate students and clinical residents]. Poltava; 2017. 113 p. Ukrainian
Загрузки
Опубликован
Как цитировать
Выпуск
Раздел
Лицензия
Copyright (c) 2024 Medicni perspektivi
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.